Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need
Last December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will be converging at the first industry led Glioblastoma Drug Development Summit under a common goal of accelerating the practical discovery, translation and clinical development of safe, effective and deliverable therapies to treat glioblastoma.
2020 Event – December 8-10, 2020